28 May 2025
Hardide plc
("Hardide" or "the Group" or "the Company")
Director Dealings
Hardide plc (AIM: HDD), the developer and provider of advanced surface coating technology, announces that on 28 May 2025, the following director of Hardide purchased ordinary shares of £0.04 each in the Company ("Ordinary Shares") at a price of 7.88 pence per ordinary share.
| PDMR/Director | Position | Shares purchased |
| Dr Bryan Allcock | Non-Executive | 63,451 |
Following the purchase of Ordinary Shares detailed above, the Director's interest in the Ordinary Share capital of the Company is as follows:
| PDMR/Director | No. of Ordinary Shares held | % of issued share capital |
| Dr Bryan Allcock | 63,451 | 0.1% |
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.
Enquiries:
| Hardide plc |
|
| Matt Hamblin (Chief Executive Officer) Simon Hallam (Chief Financial Officer) | Tel: +44 (0)1869 353830
|
| Cavendish Capital Markets Ltd - Broker and Nominated Adviser | |
| Henrik Persson / Elysia Bough (Corporate Finance) Jasper Berry / Dale Bellis (Sales)
| Tel: +44 (0) 2072 200 500 |
Notes to editors:
Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency as well as a reduced carbon footprint. Customers include leading companies operating in the energy sectors, valve and pump manufacturing, industrial gas turbine, precision engineering and aerospace industries.
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Dr Bryan Allcock | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Non-Executive Director | ||||
| b) | Initial notification/ Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Hardide plc | ||||
| b) | LEI | 213800HLAUIIFKMU5G89 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 4p each GB00BJJPX768 | ||||
| b) | Nature of the transaction | Purchase of shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price |
Single transaction as in 4c) above
| ||||
| e) | Date of the transaction | 28 May 2025 | ||||
| f) | Place of the transaction | Outside a trading venue | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.